• $2.2M
    Market Cap
  • -96.36%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
2,415
0.00%
2,415
0.00%
2,415
0.00%
2,415
-97.35%
Gross Profit
-2,415
0.00%
-2,415
0.00%
-2,415
0.00%
-2,415
-97.35%
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-106,613
+7.01%
-99,625
-11.40%
-112,444
-74.95%
-448,873
+2.98%
Depreciation and Amortization Expense
51,292
-2.98%
52,870
+9.56%
48,258
-17.44%
58,450
+1,848.33%
Total Operating Expenses
393,650
+8.09%
364,188
-12.35%
415,479
-78.22%
1.9M
-18.12%
Operating Profit
N/A
N/A
-364,188
-12.35%
-415,479
-78.22%
-1.9M
-18.12%
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
0
N/A
0
N/A
0
N/A
0
N/A
Total Nonoperating Income and Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Income before Taxes
N/A
N/A
-364,188
-12.35%
-415,479
-78.22%
-1.9M
-18.12%
Income Taxes
0
N/A
0
N/A
N/A
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
N/A
N/A
-364,188
-12.35%
-415,479
-78.22%
-1.9M
-18.12%
Net Income from Continuing Operations Applicable to Common
N/A
N/A
-364,188
-12.35%
-415,479
-78.22%
-1.9M
-18.12%
Basic EPS and Net Income
0.00
N/A
0.00
+100.00%
-0.01
N/A
N/A
N/A
Diluted EPS and Net Income
0.00
N/A
0.00
+100.00%
-0.01
N/A
N/A
N/A
Basic Weighted Average Shares
386.3M
+7.73%
358.6M
+7.64%
333.1M
+8.36%
307.4M
+5.32%
Diluted Weighted Average Shares
386.3M
+7.73%
358.6M
+7.64%
333.1M
N/A
N/A
N/A
Balance Sheet
Cash and Cash Equivalents
1,118
-94.52%
20,408
0.00%
20,408
-20.13%
25,550
-55.62%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
1,118
-94.52%
20,408
0.00%
20,408
-20.13%
25,550
-55.62%
Total Current Assets
1,050
0.00%
1,050
-95.11%
21,458
-19.33%
26,600
-68.17%
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Assets
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Assets
483,374
+3.70%
466,137
-3.00%
480,557
+3.82%
462,870
+3.73%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
0
N/A
Total Current Liabilities
185,434
+49.49%
124,047
+177.53%
44,696
+7.62%
41,530
-55.47%
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Liabilities
185,434
+49.49%
124,047
+177.53%
44,696
+7.62%
41,530
-55.47%
Retained Earnings
-48.6M
+0.82%
-48.2M
+0.76%
-47.9M
+0.88%
-47.4M
+4.19%
Total Stockholders Equity
297,940
-12.91%
342,090
-21.51%
435,861
+3.45%
421,340
+19.37%
Total Shares Outstanding
406.8M
+9.40%
371.9M
+7.41%
346.2M
+7.23%
322.9M
+8.57%
Cash Flow
Cash from Operating Activities
-135,377
-39.31%
-223,050
-40.68%
-375,989
-53.27%
-804,669
-9.58%
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
-56,308
-3.01%
-58,055
-1.86%
-59,153
-55.20%
-132,049
+45.13%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
197,500
-22.85%
256,000
-40.47%
430,000
-52.47%
904,700
+7.07%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
N/A
N/A
-76.94%
-12.65%
-88.08%
-79.01%
-419.60%
-17.55%
Return on Equity
N/A
N/A
-93.63%
-3.42%
-96.94%
-80.32%
-492.65%
-17.81%
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
0.006
-32.94%
0.009
-98.23%
0.48
-25.04%
0.64
-28.51%
Cash Ratio
0.006
-96.35%
0.16
-63.97%
0.46
-25.78%
0.62
-0.32%
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow